HomeHEM • CVE
add
Hemostemix Inc
Previous close
$0.090
Year range
$0.035 - $0.11
Market cap
9.92M CAD
Avg Volume
77.83K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 361.23K | -6.94% |
Net income | -519.34K | -82.26% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -361.21K | 6.93% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 103.75K | -32.77% |
Total assets | 243.78K | -20.10% |
Total liabilities | 8.60M | 19.63% |
Total equity | -8.36M | — |
Shares outstanding | 87.12M | — |
Price to book | -0.90 | — |
Return on assets | -534.15% | — |
Return on capital | 25.38% | — |
Cash Flow
Net change in cash
| (CAD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -519.34K | -82.26% |
Cash from operations | 68.68K | 117.10% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | 68.68K | 158.20% |
Free cash flow | 117.98K | 117.05% |
About
Headquarters
Website
